News
In this week’s edition of InnovationRx, we look at the impact of Medicaid cuts, a $400 million obesity bet, a study of bias ...
FDA and Novo Nordisk warn about counterfeit Ozempic in the U.S. with fake serial numbers, posing risks due to unknown ...
The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...
We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a ...
(CNN) - The Food and Drug Administration is warning of fake Ozempic that could pose a safety risk. The FDA and Ozempic ...
The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.
A clinical practice guideline that stresses a multidisciplinary approach is intended to help clinicians manage obesity in ...
Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...
Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.
Hermes, famed for its silk scarves as well as its handbags, secured top spot after shares in LVMH plunged following a worse ...
PARIS] Hermes’ market capitalisation surpassed that of rival LVMH, the conglomerate which tried to buy the maker of the ...
Pfizer decided to abort the clinical trial of its daily weight loss pill 'Danuglipron' after one patient in a trial showed signs of liver damage, likely to be caused by the drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results